@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SXTZVWC5-N
  skos:prefLabel "Glycyrrhetinic Acid"@en, "Énoxolone"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-B7ZZ52ND-N .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-LD3NXJ47-1
  skos:prefLabel "Anti-Ulcer Agents"@en, "Antiulcéreux"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-B7ZZ52ND-N
  dc:created "1974-11-11"^^xsd:date ;
  skos:hiddenLabel "18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate"@en, "Duogastrone"@en, "Carbenoxolone Disodium Salt"@en, "Biogastrone"@en, "Carbosan"@en, "Carbénoxolone de sodium"@fr, "Pharmaxolon"@en, "Carbénoxolone sodique"@fr, "18alpha-Carbenoxolone"@en, "Bioral"@en, "Glycyrrhetinic Acid 3-O-hemisuccinate"@en, "Sanodin"@en, "Carbenoxolone Sodium"@en ;
  mesh:allowableQualifier jvr:-W6SQV79N-S, jvr:-G30ZJ446-J, jvr:-CB30NGKB-3, jvr:-NFTHND7Q-8, jvr:-T9HQD7ST-J, jvr:-R0ZCQ8X6-J, jvr:-BT300B3G-Q, jvr:-M63HSDM7-1, jvr:-NKM836P1-M, jvr:-NHL3D2X0-S, jvr:-HQRFT0C6-B, jvr:-L6C0XPHT-4, jvr:-S0CS1X5R-5, jvr:-G4R176S9-J, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-FWD2BGQ0-9, jvr:-XV06LPML-W, jvr:-H7K65Q8S-Z, jvr:-NB0XHT3S-N, jvr:-TJHVZCRZ-0, jvr:-SBNWSM1T-R, jvr:-THHNVC7V-3, jvr:-D0F21513-5, jvr:-WK5F724J-1 ;
  skos:prefLabel "Carbenoxolone"@en, "Carbénoxolone"@fr ;
  a skos:Concept, mesh:Descriptor ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D002229> ;
  skos:altLabel "Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3beta,20beta)-"@fr, "Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3beta,20beta)-"@en, "F1MP7242Z5"@fr, "F1MP7242Z5"@en, "7421-40-1 (di-Na salt)"@fr, "7421-40-1 (di-Na salt)"@en, "Carbenoxalone"@en, "5697-56-3 (Carbenoxolone)"@fr, "5697-56-3 (Carbenoxolone)"@en, "MM6384NG73"@fr, "MM6384NG73"@en, "Carbeneoxolone"@en ;
  dc:established "1991-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  dc:modified "2016-07-01"^^xsd:date ;
  skos:broader jvr:-SXTZVWC5-N ;
  skos:definition "An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity."@en ;
  mesh:pharmacologicalAction jvr:-LD3NXJ47-1 .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .